A prospective economic analysis of Canadian Cancer Trials Group CLC.2/Alliance A041202: A randomized phase III comparison of bendamustine-rituximab versus ibrutinib-based regimens in untreated older patients with chronic lymphocytic leukemia
- Citation:
- Blood vol 136 (Supplement 1) 27-30
- Meeting Instance:
- ASH 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3561
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180863 and #704970 (CCTG)
- Corr. Author:
- Authors:
- Matthew C. Cheung Nicole Mittmann Carolyn Owen Nizar Abdel-Samad Graeme Fraser Selay Lam Michael Crump Catherine Sperlich Richard van der Jagt Anca Prica Stephen Couban Jennifer A. Woyach Amy Stark Allison M. Booth Sumithra J. Mandrekar Gail McDonald Lois E. Shepherd Hope Yen Bingshu E. Chen Annette E. Hay
- Networks:
- LAPS-MN026, LAPS-OH007
- Study
- Alliance-A041202
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: